Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Technical Analysis

278 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Immuneering’s (IMRX) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Immuneering is a Buy.
Immuneering’s (IMRX) 20-Day exponential moving average is 2.03, while Immuneering’s (IMRX) share price is $1.9, making it a Sell.
Immuneering’s (IMRX) 50-Day exponential moving average is 1.99, while Immuneering’s (IMRX) share price is $1.9, making it a Sell.

Immuneering (IMRX) Pivot Points

Nov 10, 2024, 01:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.80
1.85
1.89
1.94
1.98
2.03
2.07
Fibonacci
1.85
1.88
1.91
1.94
1.97
1.99
2.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immuneering (IMRX) Moving Averages

Nov 10, 2024, 01:55 AM
Period
Simple
Exponential
MA5
1.91Sell
1.92Sell
MA10
1.93Sell
1.95Sell
MA20
2.04Sell
2.03Sell
MA50
2.10Sell
1.99Sell
MA100
1.65Buy
2.04Sell
MA200
2.47Sell
3.04Sell
Immuneering’s (IMRX) 10-Day exponential moving average is 1.95, while Immuneering’s (IMRX) share price is $1.9, making it a Sell.
Immuneering’s (IMRX) 100-Day exponential moving average is 2.04, while Immuneering’s (IMRX) share price is $1.9, making it a Sell.
Immuneering’s (IMRX) stock price is $1.9 and Immuneering’s (IMRX) 50-day simple moving average is 2.10, creating a Sell signal.
Immuneering’s (IMRX) stock price is $1.9 and Immuneering’s (IMRX) 100-day simple moving average is 1.65, creating a Buy signal.
Immuneering’s (IMRX) stock price is $1.9 and Immuneering’s (IMRX) 200-day simple moving average is 2.47, creating a Sell signal.

Immuneering (IMRX) Technical Indicators

Nov 10, 2024, 01:55 AM
Name
Value
Implied Action
RSI (14)
43.64
Neutral
STOCH (9,6)
31.16
Neutral
STOCHRSI (14)
26.54
Neutral
MACD (12,26)
-0.07
Buy
ADX (14)
16.78
Buy
Williams %R
-75.61
Buy
CCI (14)
-96.31
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
46.17
Neutral
ROC
-12.04
Sell
Immuneering’s (IMRX) Relative Strength Index (RSI) is 43.64, creating a Neutral signal.
Immuneering’s (IMRX) Trend Strength Indicator (ADX) is 16.78, creating a Buy signal.
Immuneering’s (IMRX) Commodity Channel Index (CCI) is -96.31, creating a Neutral signal.
Immuneering’s (IMRX) Price Rate of Change (ROC) is -12.04, creating a Sell signal.

FAQ

Is IMRX a Buy, Hold, or Sell?
Based on IMRX’s technical indicators, IMRX is a Sell.
    What is IMRX’s RSI (14)?
    IMRX’s RSI (14) is 43.64, which suggests IMRX is a Neutral.
      What is IMRX’s MACD?
      IMRX’s MACD is -0.07, which suggests IMRX is a Buy.
        What is IMRX’s 5-day moving average?
        IMRX’s 5-day moving average is 1.91, which suggests IMRX is a Sell.
          What is IMRX’s 20-day moving average?
          IMRX 20-day moving average is 2.04, which suggests IMRX is a Sell.
            What is IMRX’s 50-day moving average?
            IMRX’s 50-day moving average is 2.10, which suggests IMRX is a Sell.
              What is IMRX’s 200-day moving average?
              IMRX’s 200-day moving average is 2.47, which suggests IMRX is a Sell.
                What is IMRX’s Williams % R (14)?
                IMRX’s Williams % R (14) is -75.61, which suggests IMRX is a Buy.
                  What is IMRX’s CCI (14)?
                  IMRX’s CCI (14) is -96.31, which suggests IMRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis